43,391,96,391,96,402,43,402,EXPLOSIVE
43,412,96,412,96,426,43,426,FLAMMABLE
42,432,109,432,109,443,42,443,RADIOACTIVE
74,471,109,471,109,484,74,484,SOLID
70,489,106,489,106,497,70,497,LIQUID
42,504,110,504,110,515,42,515,PRESSURIZED
215,476,285,476,285,497,215,497,Colorless
123,483,134,483,134,496,123,496,X
289,486,321,486,321,496,289,496,COLOR
399,133,414,133,414,153,399,153,1
592,131,646,131,646,152,592,152,642-138
682,17,745,17,745,48,682,48,B166
471,183,527,183,527,197,471,197,SIGNATURE:
538,161,648,161,648,200,538,200,D.
532,158,552,158,552,175,532,175,
563,162,608,162,608,176,563,176,
531,233,587,233,587,253,531,253,9/28/83
654,235,706,235,706,250,654,250,20.845
425,472,439,472,439,485,425,485,☑
627,459,691,459,691,470,627,470,DESSICATOR
627,476,673,476,673,487,627,487,FREEZER
628,492,660,492,660,505,628,505,OTHER
183,230,217,230,217,248,183,248,B166
349,162,383,162,383,177,349,177,3212
605,413,620,413,620,426,605,426,☑
693,810,713,810,713,906,693,906,00866042
304,74,555,74,555,125,304,125,HAZLETON LABORATORIES AMERICA INC
41,82,174,82,174,100,41,100,PROJECT SHEET
581,77,743,77,743,116,581,116,9200 EESAURG TURNPIKE VIENNA VIRGINIA 22180 USA
45,140,110,140,110,153,45,153,DATE ISSUED
123,130,220,130,220,150,123,150,Oct. 11, 1983
278,141,376,141,376,156,278,156,PROJECT SHEET NO.
480,141,568,141,568,157,480,157,PROJECT NO.
46,159,211,159,211,172,46,172,STUDY TITLE & PROPOSAL NUMBER
49,173,374,173,374,193,49,193,Acute Intraperitoneal Toxicity Study in Rats
420,161,531,161,531,175,420,175,PROJECT COORDINATOR
419,204,480,204,480,217,419,217,LOT NO.(s)
527,204,611,204,611,219,527,219,RECEIPT DATE(s)
659,208,732,208,732,219,659,219,LH- NUMBER(s)
45,201,134,201,134,215,45,215,TEST MATERIAL(s)
47,291,174,291,174,306,47,306,PERFORMING DEPARTMENTS
176,292,306,292,306,306,176,306,4 COPIES EACH DIRECTOR)
47,303,224,303,224,319,47,319,Acute/ Dermal Toxicology
43,355,225,355,225,371,43,371,PROTECTIVE PRECAUTIONS REQUIRED:
165,369,268,369,268,382,165,382,HAZARDOUS, COMPOUND
211,391,309,391,309,405,211,405,CARCINOGEN (OSHA)
211,413,315,413,315,426,211,426,CARCINOGEN (OTHER)
45,451,163,451,163,466,45,466,PHYSICAL DESCRIPTION:
45,522,175,522,175,537,45,537,EXPERIMENTAL PROCEDURES
189,522,579,522,579,542,189,542,to performed in Acure/Dermal Toxicology, building 18.
422,295,628,295,628,310,422,310,ORIGINAL SIGNED PROJECT SHEETS TO PSO
472,316,584,316,584,329,472,329,FIXED DISTRIBUTION:
587,317,725,317,725,387,587,387,(1 COPY TO EACH) LAB ANIMAL MEDICINE QUALITY ASSURANCE CONTRACTS Sponsor
430,334,539,334,539,392,430,392,DIR. OF LIFE SCIENCES HEALTH SERVICES COMPOUND PREP (TOX) SCIENTIFIC RES TOX
420,404,582,404,582,427,420,427,FOLLOW DEPARTMENT AND COMPANY SAFETY MANUALS
423,439,523,439,523,454,423,454,STORAGE CONDITIONS
437,455,511,455,511,469,437,469,STORE IN DARK
437,469,542,469,542,488,437,488,REFRIGERATOR 8 C
437,489,530,489,530,502,437,502,ROOM TEMPERATURE
437,504,615,504,615,519,437,519,SPECIAL INSTRUCTIONS WHILE DOSING
91,574,383,574,383,591,91,591,The protocol for this study is attached.
95,602,531,602,531,620,95,620,The protocol was approved in sponsor letter of June 6, 1983.
92,630,543,630,543,651,92,651,The anticipated initiation date of this study is October 1983.
91,659,550,659,550,681,91,681,The anticipated completion date of this study is November 1983.
49,961,123,961,123,983,49,983,ML FORM NO. 5 REVISED 1- 81
